This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fair Warning: If you ever dismissively ask that question (above) of someone who’s led the planning and launch of a 340B hospital’s specialtypharmacy, and did it with no outside support, there’s a good chance you’ll get punched. POST OUTLINE Why is it so hard to build a 340B specialtypharmacy? Yes, it’s that difficult.
Fair Warning: If you ever dismissively ask that question of someone whos led the planning and launch of a 340B hospitals specialtypharmacy, and did it with no outside support, theres a good chance youll get punched. WHY is it so hard to build a 340B specialtypharmacy? Yes, its that difficult.
Stephen Davis, PharmD, senior director of Health System Strategy at Shields, and Erica Diamantides, PharmD, specialtypharmacymanager at UW Medicine, discuss the current guidance and best practice for specialtypharmacy accreditations.
A clinical pharmacy specialist and specialtypharmacymanager from Allegheny Health Network urge patients to use their pharmacist in the treatment management of arthritis.
Within this expansive network, the neurology clinical pharmacy specialist serves a vital dual role. The position ensures continuous care coordination and medication oversight across the system’s specialtypharmacy and neurology practices. 1 Evidence from recent studies supports the effectiveness of this approach.
This single-center, retrospective, observational study included data from electronic health records and specialtypharmacies from January 1, 2023, to June 1, 2024, with specialtypharmacy dispensing data specifically used to identify patients who had received Humira and a biosimilar during the study period.
As a specialtypharmacy that works with nurses and medical assistants every day, we hear about your hectic schedules. Courtney Manasco, RPH, is a PharmacyManager at Amber SpecialtyPharmacy. The post 10 Opportunities to Leverage for Career Advancement appeared first on Amber SpecialtyPharmacy.
One thing I’d like to mention: before our specialtypharmacy got involved, it was very difficult to treat these patients, because all the prior authorizations went through the office. You basically had secretaries or admins trying to manage this complex field with these specialty drugs.
Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC, director at Pericardial Disease Center and professor of medicine, and Sean Krohn, PharmD, CSP, MSCS, lead clinical pharmacist, specialtypharmacy, discussed a complex case of severe pericarditis in an elderly patient who could not tolerate traditional treatments like NSAIDs or colchicine.
So we are licensed by the medical board and also by the board of pharmacy. So we'll send the prescriptions that they need to our specialtypharmacy and then get those meds and bring them to the patient prior to them ever coming to transplant and go, “Okay, these are the meds you're going to take.
Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC, director at Pericardial Disease Center and professor of medicine, and Sean Krohn, PharmD, CSP, MSCS, lead clinical pharmacist, specialtypharmacy, focused on rilonacept's mechanism of action in treating recurrent pericarditis.
Although the value of pharmacists within health care teams is well-recognized, their specific impact on identifying and mitigating DTPs in adult patients with cancer who are new to treatment—particularly in a community-based specialtypharmacy setting—has been less understood.
We have pharmacy technicians at our specialtypharmacy who specialize in the prior authorization process to help expedite initiation of treatment. They also handle the prior auth approvals for continuation of therapy to avoid any potential gaps in the patient's treatment.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content